Colitis, Ulcerative
Showing 1 - 25 of 157
Therapeutic Endpoint in Pediatric IBD Conditions
Not yet recruiting
- Inflammatory Bowel Diseases
- +2 more
- AlgometRx Nociometer
- (no location specified)
Sep 27, 2023
Colitis, Ulcerative Trial in Cambridge (GSK4381406, Placebo, Indomethacin)
Not yet recruiting
- Colitis, Ulcerative
- GSK4381406
- +2 more
-
Cambridge, United KingdomGSK Investigational Site
Aug 11, 2023
Medicine Called Infliximab[Infliximab Biosimilar 3] in People
Not yet recruiting
- Arthritis, Rheumatoid
- +3 more
- (no location specified)
Mar 31, 2023
Crohn Disease, Colitis, Ulcerative Trial (TEV-48574 Dose Regimen A, TEV-48574 Dose Regiment B)
Recruiting
- Crohn Disease
- Colitis, Ulcerative
- TEV-48574 Dose Regimen A
- TEV-48574 Dose Regiment B
-
Kissimmee, FloridaTeva Investigational Site 15357
Feb 2, 2023
Colitis, Ulcerative Trial in Worldwide (Ustekinumab Dose Based on BSA and Body Weight, Matching Placebo)
Recruiting
- Colitis, Ulcerative
- Ustekinumab Dose Based on BSA and Body Weight
- Matching Placebo
-
Wilmington, Delaware
- +68 more
Jan 31, 2023
IBD, Colitis, Ulcerative Trial in Australia, United States (MORF-057, Placebo)
Recruiting
- Inflammatory Bowel Diseases
- Colitis, Ulcerative
- MORF-057
- Placebo
-
Sun City, Arizona
- +13 more
Jan 24, 2023
Colitis, Ulcerative Trial in Worldwide (Spesolimab IV infusion, Spesolimab SC solution for injection)
Active, not recruiting
- Colitis, Ulcerative
- Spesolimab IV infusion
- Spesolimab SC solution for injection
-
Hamden, Connecticut
- +37 more
Jan 23, 2023
A Study of Vedolizumab in Adults in Real-World Practice
Recruiting
- Colitis, Ulcerative
- Crohn Disease
-
Beijing, Beijing, China
- +37 more
Jan 17, 2023
Colitis, Ulcerative Trial in Worldwide (Cobitolimod, Placebo)
Colitis, Ulcerative, IBD Trial in Worldwide (Placebo IV, Placebo SC, Ustekinumab IV)
Completed
- Colitis, Ulcerative
- Inflammatory Bowel Diseases
- Placebo IV
- +3 more
-
Birmingham, Alabama
- +253 more
Jan 3, 2023
IBD, Colitis, Ulcerative Trial in Poland, United States (MORF-057)
Recruiting
- Inflammatory Bowel Diseases
- Colitis, Ulcerative
-
Miami, Florida
- +23 more
Dec 20, 2022
Inflammatory Bowel Disease, Colitis, Ulcerative, Crohn Disease Trial in Groningen (LMT503, Placebo)
Not yet recruiting
- Inflammatory Bowel Disease
- +2 more
- LMT503
- Placebo
-
Groningen, NZ, NetherlandsICON plc Company - Early Development Services
Dec 13, 2022
Colitis, Ulcerative Trial in Worldwide (BMS-986165, Placebo Comparator)
Recruiting
- Colitis, Ulcerative
- BMS-986165
- Placebo Comparator
-
San Diego, California
- +25 more
Dec 15, 2022
Ulcerative Colitis, Colitis, Ulcerative Trial (biological, drug, other)
Not yet recruiting
- Ulcerative Colitis
- Colitis, Ulcerative
- VE202
- +3 more
- (no location specified)
Nov 29, 2022
Participants Receiving Flixabi or Imraldi: a French Cohort Study
Completed
- Arthritis, Rheumatoid
- +4 more
-
Caluire et Cuire, Auvergne-Rhône-Alpes, France
- +59 more
Oct 17, 2022
Pattern in Moderate to Severe Inflammatory Bowel Disease in Real
Completed
- Colitis, Ulcerative
- +2 more
-
Minsk, Minsk Region, Belarus
- +35 more
Oct 4, 2022